Table 3.
Symptoms at Follow-up Stratified by Sex
| Outcome | Overall | Sex | Adjusted Log (Odds Ratio) | 95% Confidence Interval | P Value | |
|---|---|---|---|---|---|---|
| Female (Reference) | Male | |||||
| Any one of the following symptoms | 244 (81%) | 138 (84%) | 106 (77%) | −0.76 | −1.41 to −0.13 | .020 |
| Fatigue and weakness | 158 (52%) | 94 (57%) | 64 (46%) | −0.57 | −1.06 to −0.09 | .022 |
| Muscle and joint pain | 144 (48%) | 83 (50%) | 61 (44%) | −0.40 | −0.89 to 0.08 | .101 |
| Sleep disorders | 141 (47%) | 84 (51%) | 57 (41%) | −0.52 | −1.01 to −0.04 | .034 |
| Respiratory disorders | 110 (36%) | 63 (38%) | 47 (34%) | −0.26 | −0.75 to 0.23 | .295 |
| Neurological and cognitive impairments | 110 (36%) | 66 (40%) | 44 (32%) | −0.46 | −0.95 to 0.03 | .069 |
| Sensory alterations | 84 (28%) | 53 (32%) | 31 (22%) | −0.55 | −1.09 to −0.02 | .044 |
| Movement impairments | 54 (18%) | 33 (20%) | 21 (15%) | −0.39 | −1.01 to 0.22 | .218 |
| Gastrointestinal symptoms | 35 (12%) | 21 (13%) | 14 (10%) | −0.34 | −1.09 to 0.39 | .363 |
Bold text indicates significant P value (P < .05).